Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206815
Company: NOVELGENIX THERAPS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription AA No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/18/2016 ORIG-1 Approval STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/21/2020 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

SODIUM POLYSTYRENE SULFONATE

POWDER;ORAL, RECTAL; 454GM/BOT
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KALEXATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 040905 KVK TECH
KIONEX SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 040029 PADDOCK LLC
SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 205727 BELCHER
SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 089910 CMP PHARMA INC
SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 206815 NOVELGENIX THERAPS
SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE 454GM/BOT POWDER;ORAL, RECTAL Prescription No AA 204071 NUVO PHARMS INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English